Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Nokian Renkaat Oyj ADR NKRKY

Nokian Tyres PLC makes and sells rubber tires under the Nokian brand name for automobiles, commercial vans, and commercial trucks. The... see more


Bullboard (PINL:NKRKY)

View:
User Avatar Image
(3)
•••
  • CoressPringsX
Post by CoressPringson Apr 13, 2023 3:01am

Kevin Harrington Discusses FSD Pharma

I believe this new product will aid society in reducing the ...more  

Hispania Resources Acquires Lumbrales Deposit Permit, Aims for Continued Growth in Spain's Mining Sector

Norman Brewster, CEO, said, "We are extremely excited about the acquisition of the Lumbrales permit and our expansion in Spain. The property is located in the Stanniferous Iberian Belt, a geological region our team is familiar with. This property has been a previous producer of Tin, now considered a critical metal. Given the current market forecasts of Tin, this property holds considerable ...read more
User Avatar Image
(3)
•••
  • CoressPringsX
Post by CoressPringson Apr 30, 2022 2:41am

Lucid-MS for Multiple Sclerosis Treatment

User Avatar Image
(3)
•••
  • CoressPringsX
User Avatar Image
(3)
•••
  • CoressPringsX
Post by CoressPringson Apr 15, 2022 8:51am

FSD Pharma Inc: Lucid MS Video

FSD Pharma is delighted to announce pre-clinical findings ...more  

Thematica Insights Report and Investor Guide

Beyond Precious

An investor's guide to precious metals and their potential in today's market. Click here to access the report.
User Avatar Image
(3)
•••
  • CoressPringsX
Post by CoressPringson Apr 09, 2022 12:50am

FSD: Cancellation of Certain Shares Issued to Former CEO

FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ...more  
User Avatar Image
(3)
•••
  • CoressPringsX
Post by CoressPringson Apr 07, 2022 1:45am

FSD Pharma Issues Corporate Updates

FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to ...more  
User Avatar Image
(3)
•••
  • CoressPringsX
Post by CoressPringson Apr 06, 2022 12:53am

iMining: First Hospital Foundation in Decentraland Metaverse

iMining Enters into Agreement for the First-Ever Hospital Foundation to Be Launched in the Decentraland Metaverse   Vancouver, British Columbia--(Newsfile Corp.) - iMining Technologies Inc ...more  
User Avatar Image
(3)
•••
  • CoressPringsX
Post by CoressPringson Feb 04, 2022 2:47am

FSD Pharma Inc: Lucid MS Video

FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid ...more  
User Avatar Image
(3)
•••
  • CoressPringsX
Post by CoressPringson Dec 30, 2021 9:11pm

FSD Pharma Announces Share Repurchase Program

FSD Pharma Announces Share Repurchase Program   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding ...more  
User Avatar Image
(3)
•••
  • CoressPringsX
Post by CoressPringson Dec 10, 2021 1:10am

FSD Pharma Establishes New Regulatory Advisory Board

FSD Pharma Establishes New Regulatory Advisory Board with the Appointment of Joga Gobburu, Ph.D., and Mary Melnyk, Ph.D., as Members   Regulatory Advisory Board will oversee the drug development ...more